The in vivo molt-inhibitory effects of the ecdysone biosynthesis inhibitors 3-hydroxy-L-kynurenine and xanthurenic acid were investigated. These ecdysone biosynthesis inhibitors, isolated from the eyestalks of blue crabs (Callinectes sapidus), were i jected into eyestalk-ablated crayfish (Procambarus clarkii). The active factor was found to be species-nonspecific within crabs and crayfish. The seasonal profres of the xanthurenic acid and ecdysone titers exhibited a staggered relationship. Moreover, the activity of a 3-hydroxy-L-kynurenine aminotransferase varied during the molting cycle.
In crustaceans, growth is linked to the periodic shedding and reformation of the exoskeleton, and the molting cycle is hormonally controlled and associated with environmental cues, including light and temperature. It has long been known that initiation of molting is triggered by progressive increases in the titer of the circulating molting hormone, 20-hydroxyecdysone (1) , which is a metabolite of ecdysone.
The existence of a molt-inhibiting substance, or so-called molt-inhibiting hormone (MIH), was established by the observations that eyestalk ablation results in a significant acceleration of the molting cycle and that injection of extracts of the eyestalk neurosecretory X-organ-sinus gland complex delays the molting of eyestalk-ablated animals (2) (3) (4) . When it was demonstrated that incubation of Y-organs in vitro leads to the biosynthesis of the pro-molting hormone, ecdysone (5, 6) , a plausible rationalization was that MIH acts by inhibiting this ecdysteroidogenesis in the Y-organ. A decrease in the biosynthesis of ecdysone by the Y-organ would reduce the body fluid concentration of the active hormone, 20-hy--droxyecdysone. It has been proposed to define MIH as a factor that can delay the onset of ecdysis and lengthen the interval between successive molts. However, MIH could also act by increasing the rates of metabolism or excretion of ecdysteroids or by antagonizing 20-hydroxyecdysone at the epidermis. Indeed, the eyestalk extract of the shrimp Palaemonetes vulgaris was shown to suppress the apolysisstimulating action of 20-hydroxyecdysone in Balanus amphitrite mantle tissue (7) . Attempts to isolate MIH have involved the use of either in vivo or in vitro bioassays. In vivo assays were employed in the isolation of an 8.7-kDa peptide from the sinus glands of Homarus americanus (8) and another compound, believed to be an indolylalkylamine, from the eyestalk of Pandalusjordani (9) . The latter compound inhibited molting in young Orchestia traskiana (9) and was later identified as 3-hydroxy-L-kynurenine (3-OH-K) (10) .
In vitro incubation of Y-organs (11) (2) were isolated from Callinectes sapidus, Portunus trituberculatus, Geothelphusa dehaai (10), and Procambarus clarkii (this paper); a proteinaceous material could have been present in an unexplored active G-25 fraction in our studies (10) . A mechanism was proposed to explain the ecdysone biosynthesis inhibitors activities of 3-OH-K and XA (10) .
Ecdysteroidogenesis occurred in the supernatant obtained by centrifugation ofthe Y-organ complex homogenate at 7700 x g, and was inhibited by eyestalk extract (10) ; therefore, the cell membrane may not be the site of the action of ecdysone biosynthesis inhibitors. The eyestalk extract containing ecdysone biosynthesis inhibitor(s) was shown to be speciesnonspecific with respect to the eyestalk source and Y-organ complex donor among four species of crabs (10) and crayfish.
Recently, it was suggested (13) that an initial small release of ecdysteroid triggers the transition from intermolt to premolt gene expression in the crayfish Astacus leptodactylus, thus initiating the proecdysial period. The first release is then followed by a second surge to higher ecdysteroid concentrations. Furthermore, precocious molting observed in Yorganless animals after multiple autotomy (14) suggested that a mechanism may exist for the storage of ecdysteroids outside the Y-organ (15) .
Taking these results into account, we investigated the physiological roles of the inhibitor(s) 3-OH-K and XA with respect to prolonging the interval between successive molts in eyestalk-ablated crayfish Procambarus clarkii. We also examined the hormonal properties of 3-OH-K and XA. We report here the results of our experiments.
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MATERIALS AND METHODS Animals. The freshwater crayfish Procambarus clarkii used in this study were collected in a pond at Akashi City, Japan, over a 2-week period at the beginning of August 1987 and during the same period in August 1988. The crayfish were maintained for several days in running tap water at the normal seasonal temperature and photoperiod. For each experiment a selection was made as stated below.
The seawater crabs Charybdis japonica used in the seasonal variation studies were collected by Iwami Fishing Association in Hyogo Prefecture off the coast of Iwami, Japan, in 1986-1987. They were brought into the laboratory and used while alive. Intermolt stage animals with a carapace width of 60-80 mm were used.
3-OH-K and XA Injection. Authentic 3-OH-K (reagent grade guaranteed) was purchased from Wako Pure Chemicals (Osaka, Japan) and XA (reagent grade guaranteed) from Nakarai Chemical (Kyoto, Japan). Crayfish in the intermolt stage, 7-8 cm long and weighing =30 g after towel drying, were randomly divided into several entry groups that consisted of 10-15 animals each of both sexes. They were bilaterally de-eyestalked and forced to autotomize their chelae on the same day. Beginning on the next day, 3-OH-K (30 or 100 ng per animal) or XA (10 or 30 ng per animal) in 100
A.l ofgeneral crustacean physiological saline (16) was injected daily (control animals were injected with 100 Aul of saline), and the number of animals that had shed their exoskeletons was tallied each day for two successive molting cycles. Another control group consisted of intact animals (with eyes) that were injected with 100 1.l of saline each day.
Exposure to XA Solution. Ten animals were maintained in a tank of water containing XA (20 mg per 10 liters of water) for 24 days. The XA solution was replaced daily.
HPLC. For HPLC separation and analysis, a Shimadzu LC-3A or LC-6A instrument equipped with a Chromatopac C-R2AX data processor and an SPD-2A or SPD-6A UV detector was employed. Conditions used for 3-OH-K were as follows: (i) separation by gel permeation on an Asahipak GS-320 7.6 mm x 500 mm column with 9-,um particle size (Asahi Chemical) and detection at 240 nm with 0.17 M ammonium acetate (pH 5) as eluent (flow rate 1.0 ml/min; elution time 32-36 min); (ii) analysis on a reverse-phase Microsorb C18 4.6 mm x 250 mm column with 5-,um particle size (Rainin Instruments) and detection at 240 nm with 0.17 M ammonium acetate (pH 5) as eluent (flow rate 1.0 ml/min; elution time 7 min). Conditions used for XA were as follows: (i) separation by gel permeation as above with 10%0 acetonitrile/0.17 M ammonium acetate (pH 5) as eluent (flow rate 2.0 ml/min, elution time 28-36 min); (ii) analysis by gel permeation as above with 20o acetonitrile/0.17 M ammonium acetate (pH 5) as eluent (flow rate 2.0 ml/min; elution time 17 min).
Ecdysteroids were first separated on a normal-phase APSHypersil (Shandon) 4.6 mm x 250 mm column with 5-,um particle size and detected at 254 nm with methylene chloride/ isopropanol/water (75/15/1) as eluent (flow rate 1.0 ml/min, elution time 8-12 min for ecdysone and 12-16 min for 20-hydroxyecdysone); separation was followed by analysis on a reverse-phase Cosmosil SC18 4.6 mm x 250 mm column with 5-gum particle size (Nacalai Tesque) and detection at 247 nm with methanol/acetonitrile/water (30/10/60) as eluent (flow rate 0.8 ml/min for ecdysone and 0.5 ml/min for 20-hydroxyecdysone; elution time 22 min for ecdysone and 17 min for 20-hydroxyecdysone).
HPLC Sample Preparation. Samples were prepared for HPLC by described procedures (10 exceeding the maximum physiological level of 150 ng (determined over the course of a year) of 3-OH-K per ml of hemolymph; this dosage delayed by 2 days the onset of the first molt after start ofinjections and lengthened by 3 days the interval between the first and second molts (Fig. 1) . Control animals were injected daily with saline alone. Two groups of animals, injected daily with 10 effects of XA. To obtain further information, we examined animals that had been maintained continuously for 24 days in water containing XA, but the effect of this exposure on the length of the molting interval was, again, ambiguous. Before the above preliminary experiments were done, the optimal dosage and timing of 3-OH-K injections were not known. Therefore, injections were given once daily throughout two successive molting cycles. Lowe et al. (17) found that exogenous 20-hydroxyecdysone can initiate molting of the crayfish, Procambarus simulans, only when the injection is timed correctly, e.g., 72 hr after-eyestalk removal. It is possible that 3-OH-K injection also has no effect during the first few days after operation. For these few days, the activity of the aminotransferase (apparent 3-OH-Kase) that converts 3-OH-K to XA was low, and the Y-organ was refractory to XA (see below). Later, when the conversion capability increased as a result of operation, 3-OH-K became involved in the inhibition of ecdysteroidogenesis. Thus, the time course of chemical stimulation for the Y-organ is similar to that for the prothoracic gland in insects, in which a change in enzymatic activity serves as a diapause-terminating cue (18) .
Quantitative analysis revealed that 3-OH-K injection suppressed the increase in hemolymph 20-hydroxyecdysone titer that preceded ecdysis in control animals. Thus, the 20-hydroxyecdysone concentration in hemolymph peaked at a value >30 ng/ml (average of 10 animals) in eyestalk-ablated, autotomized control animals; this value was reduced to about 5 ng/ml in animals injected daily with 3-OH-K (30 ng per 100 dul in saline). The 20-hydroxyecdysone concentration remained low for -"13 days in the 3-OH-K injected animals (8-10 cm long) and then increased to -40 ng/ml just before molting. These observations were consistent with previous accounts of the MIH effect (19, 20 Although we found both 3-OH-K and XA in the X-organ as well as in the whole eyestalk, our results indicated that 3-OH-K is a circulating ecdysone biosynthesis inhibitor that Effect ofEyestalk Ablation. The capacity ofthe hemolymph to transform 3-OH-K into XA in the presence and absence (as control) of exogenous 3-OH-K was examined. Hemolymph, withdrawn at 24-hr intervals from crayfish that were deeyestalked on day 0, was precipitated with casein, and aliquots of the supernatant were incubated at 37°C for 1 hr with or without exogenous 3-OH-K. After workup, the extent of transformation of 3-OH-K into XA was determined by HPLC quantification of XA. The transformation activity temporarily peaked on day 2 in 3-OH-K-supplemented hemolymph obtained from 10 animals that weighed -25 g and were 6-7 cm long. In hemolymph obtained from larger animals, the peak in activity was delayed by a few days. In all hemolymph samples containing exogenous 3-OH-K, the peak in transformation activity was followed by a peak in the titer of 20-hydroxyecdysone; thus, a decrease in the transformation activity presumably signals the timing for a sharp increase in the concentration of ecdysone and, subsequently, of 20-hydroxyecdysone, the active molting hormone.
The transient increase in the capacity of hemolymph to transform exogenous 3-OH-K into XA after eyestalk ablation was not accompanied by changes in the total concentration of endogenous aminotransferase substrates. The titer of total aminotransferase substrates was determined by precipitation of proteinaceous compounds from the hemolymph supernatant by picric acid, followed by ninhydrin colorimetry (21) . Thus, as demonstrated in our previous paper (10), the aminotransferase that transforms 3-OH-K into XA exhibited strong activity toward 3-OH-K; however, it is unknown whether this enzyme is a specific 3-OH-Kase. This aminotransferase was distributed in the hemolymph, the Y-organ complex and the eyestalk. The dynamics and compartmentalization of the enzymatic activity are discussed further below.
Seasonal Proffles of3-OH-K, XA, and Ecdysone. Changes in the capacity of the hemolymph to enzymatically transform 3-OH-K to XA under forced molting conditions result in regulation of the production of an ecdysone biosynthesis inhibitor XA. A surge and fall in the concentration of XA appears to be a key event in the timing of molting, as it leads to a peak in the 20-hydroxyecdysone titer and then to ecdysis. A correlation may also exist between the ecdysone and XA titers in their seasonal variations. The seasonal profiles ofthe ecdysone, 3-OH-K, and XA concentrations in the eyestalk, Y-organ complex, and hemolymph all led to the same conclusion: namely, that apparent 3-OH-Kase activity varies according to the season and location and also that XA and ecdysteroids (ecdysone and 20-hydroxyecdysone) titers maintain a staggered relationship. The Y-organ complex profile is illustrated in Fig. 2 .
(i) In the eyestalk, the 3-OH-K titer exhibited two maxima during the year, in March/April and September/October, whereas the XA titer showed little variation (data not shown). The March/April 3-OH-K peak was reflected in an increase in the 3-OH-K titer in the Y-organ complex, whereas the September/October peak was not. The September/October peak presumably preceded the conversion into metabolites other than XA, such as the eye pigment xanthommatine. The ratio of the concentration of XA to the concentration of 3-OH-K plus the concentration ofXA, which can be regarded as denoting the apparent 3-OH-Kase activity, fluctuated seasonally and peaked in June and November.
(ii) The concentration of XA in the Y-organ complex peaked in November/December (Fig. 2) . This maximum coincided with a peak in apparent 3-OH-Kase activity in the Y-organ complex and with the November peak in apparent 3-OH-Kase activity in the eyestalk. However, in the hemolymph, apparent 3-OH-Kase activity was highest in September/October (data not shown). These results revealed compartmentalization of the seasonal enzymatic activity.
(iii) There was a general staggered relationship between the XA and ecdysteroids (ecdysone and 20-hydroxyecdysone) concentrations in both the Y-organ complex (Fig. 2) and the hemolymph.
(iv) When the Y-organ complex was incubated (10) during the period of high XA titer (November/December), the concentration ofecdysone increased >100-fold, from 5 ng per Y-organ complex to >500 ng per Y-organ complex. Thus, in vivo ecdysteroidogenesis was suppressed during this period by XA, but incubation of Y-organ complex led to a dramatic acceleration in ecdysone synthesis by overriding this inhibitory effect. In February, the period following the high XA titer, the ecdysone level rose to -30 ng per Y-organ complex; incubation ofY-organ complex during this period reduced the ecdysone level to one-tenth this value. In this case, incubation accelerated metabolism of ecdysone and suppressed ecdysteroidogenesis. XA, generated from 3-OH-K during incubation, presumably was the agent responsible for inhibition of ecdysteroid synthesis. 3-Hydroxy-L-kynurenine was detected in relatively high concentration in the Y-organ complex before incubation (see Fig. 2 ).
(v) The high concentrations of both 3-OH-K and XA in the Y-organ complex (maxima =1000 ng and :300 ng per Yorgan complex, respectively) relative to their titers in the hemolymph (maxima 150 ng/ml and 10 ng/ml, respectively) suggested the presence of a putative 3-OH-K receptor at the Y-organ.
The present results, in conjunction with other reports (7) (8) (9) (10) (11) , show that crustacean molting is controlled by several factors and that the molting process is protected against excessive supplies of the ecdysis-promoting hormone by multiple safety valves. The question as to what should be called MIH and the ED"(s) of the compounds responsible for MIH activity in animal extracts remain to be clarified.
Definitive ED50 values of the ecdysone biosynthesis inhibitor(s) 3-OH-K and XA (10) are still under investigation.
